Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

telehealth

  • Home
  •  
  • telehealth



  • Most Read
  • Latest Comments
  • Doctor Care Anywhere’s Aussie Board steps down amid mass layoffs and renewed UK focus
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Doctor Care Anywhere’s Aussie Board steps down amid mass layoffs and renewed UK focus
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Doctor Care Anywhere’s Aussie Board steps down amid mass layoffs and renewed UK focus
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Doctor Care Anywhere’s Aussie Board steps down amid mass layoffs and renewed UK focus
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Doctor Care Anywhere’s Aussie Board steps down amid mass layoffs and renewed UK focus
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    • News

  • Doctor Care Anywhere’s Aussie Board steps down amid mass layoffs and renewed UK focus
    • News

    Doctor Care Anywhere’s Aussie Board steps down amid mass layoffs and renewed UK focus

    With a super on-the-nose name, it’s difficult not to know what UK-based telehealth company Doctor Care Anywhere (ASX: DOC) does. Providing people consultations no matter where they are, the Company seems to have received public favour, with a spurt in the number of returning customers and thriving subsidiaries. At the same time, this was probably

    Read More
    Public
  • Cronos shares slides 20% as company flags large holding set to come out of escrow
    • News

    Cronos shares slides 20% as company flags large holding set to come out of escrow

    Are investors panic selling their shares at medicinal cannabis company Cronos Australia (ASX: CAU)? With 73.4% of the Company’s shares to be released from voluntary escrow soon, it’s the only explanation Cronos could give to the ASX to explain the irregular trading activity.  Cronos, who became Australia’s first ever ASX-listed cannabis company to pay out

    Read More
    Public
  • Knosys secures deal to provide back of house knowledge management for government health service
    • News

    Knosys secures deal to provide back of house knowledge management for government health service

    If you’ve ever wanted to determine the cause of that ache, pain, cough or sniffle sans doctor, you’ve likely found yourself at Healthdirect’s symptom checker. Aside from hosting a hypochondriac’s best friend, Healthdirect is a valuable resource, providing free Australian health advice. The government-funded service comprises a website, a National Health Services Directory and a

    Read More
    Public
  • Pandemic shines light on hospital workflows as Austco Healthcare awarded $1.6m nurse call contract
    • News

    Pandemic shines light on hospital workflows as Austco Healthcare awarded $1.6m nurse call contract

    If there was one positive takeaway from the pandemic, it is that public health systems have upgraded their facilities for better use of resources by leveraging technology to provide better patient outcomes. In Singapore, this has been powered by Austco Healthcare (ASX: AHC) which has been awarded a $1.6m contract for its nurse call system

    Read More
    Public
  • Racing shines amid snap lockdowns as Apiam capitalises on booming veterinary market
    • News

    Racing shines amid snap lockdowns as Apiam capitalises on booming veterinary market

    With a drama filled weekend that resulted in the relocation of several AFL and NRL matches rescheduled in response to snap lockdowns, one sport remains consistent as a rock and a money spinner for Governments, having thrived since the start of the pandemic – horse racing.  At the same time as a mass exodus from

    Read More
    Public
  • ResApp study data published, further confirms app’s efficacy
    • News

    ResApp study data published, further confirms app’s efficacy

    Confirming the efficacy and broader potential of their smartphone-based diagnostic app, ResApp Health Limited (ASX: RAP) clinical data referenced in a top academic publication has validated their app’s accuracy for respiratory diagnostics. Data from their Breathe Easy adult clinical study has been published in a peer-reviewed Nature partner journal, npj Digital Medicine. The study looked

    Read More
    Public
  • 1
  • 2
  • 3
  • 4

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.